Mei Mei Hu - Jun 16, 2022 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Signature
/s/ Mei Mei Hu
Stock symbol
VAXX
Transactions as of
Jun 16, 2022
Transactions value $
$199,290
Form type
4
Date filed
6/21/2022, 04:52 PM
Previous filing
Jun 10, 2022
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VAXX Class A common stock Purchase $199K +100K +0.19% $1.99 51.7M Jun 16, 2022 Held by United Biomedical Inc. F2, F3
holding VAXX Class A common stock 272K Jun 16, 2022 Held by Blackfoot Healthcare Ventures LLC F1
holding VAXX Class A common stock 4.21M Jun 16, 2022 Held by United Biomedical Inc., Asia F4
holding VAXX Class A common stock 17.5K Jun 16, 2022 Held by spouse F5
holding VAXX Class B common stock 5.52M Jun 16, 2022 Direct F6
holding VAXX Class B common stock 3.96M Jun 16, 2022 Held by spouse F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Blackfoot Healthcare Ventures LLC ("Blackfoot"). The Reporting Person is one of two shareholders of Blackfoot and may therefore be deemed to beneficially own the securities held by Blackfoot. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Blackfoot in which the Reporting Person has no pecuniary interest.
F2 The price reported is a weighted average price.
F3 These securities are held by United Biomedical Inc. ("UBI"). The Reporting Person, Louis Reese, Nean Hu and Chang Yi Wang, together as a group, control more than 50% of the equity interests of UBI, and together share investment control of all shares held by UBI. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBI in which the Reporting Person has no pecuniary interest.
F4 Held by United Biomedical, Asia Inc. ("UBIA"). UBI, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person, Louis Reese, Nean Hu and Chang Yi Wang, together as a group, control more than 50% of the equity interests of UBI, and together share investment control of all shares held by UBI. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBI in which the Reporting Person has no pecuniary interest.
F5 These securities are held by Louis Reese, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Louis Reese in which the Reporting Person has no pecuniary interest.
F6 Class B common stock is convertible to Class A common stock on a one-for-one basis and has no expiration date.

Remarks:

Chief Executive Officer and President.